Europe’s medical devices industry saw a rise of 7.89% in deal activity during March 2022, when compared with the last 12-month average, led by Angelus Sano Fund, Segulah Medical Acceleration and Waha Capital’s $49m private equity deal with Signifier Medical Technology, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 41 medical devices industry deals worth $251m were announced for the region in March 2022, against the 12-month average of 38 deals.
Of all the deal types, venture financing saw most activity in March 2022 with 20 transactions, representing a 48.8% share for the region.
In second place was M&A with 16 deals, followed by private equity deals with five transactions, respectively capturing a 39.02% and 12.2% share of the overall deal activity for the month.
In terms of value of deals, private equity was the leading category in Europe’s medical devices industry with $106.62m, while venture financing and M&A deals totalled $84.87m and $59.5m, respectively.
Europe medical devices industry deals in March 2022: Top deals
The top five medical devices deals accounted for 60.9% of the overall value during March 2022.
The combined value of the top five medical devices deals stood at $152.92m, against the overall value of $251m recorded for the month.
The top five medical devices industry deals of March 2022 tracked by GlobalData were:
1) Angelus Sano Fund,Segulah Medical Acceleration and Waha Capital $49m private equity deal with Signifier Medical Technology
2) The $36.42m private equity of ITM Isotopen Technologien Munchen by Indigenous Critical Infrastructure Fund Canada (ICIF) and Portland Investment Counsel
3) SourceBio International $24.35m acquisition deal with LDPath
4) The $21.94m acquisition of BioClue and BioStrand by BioKey and ImmunoPrecise Netherlands
5) Heights Capital Ireland $21.2m private equity deal with Renalytix AI